Showing results (1251-1260 of 5,986) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|October 10, 2019
The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath TumorKathryn M Lemberg, Liang Zhao, Ying Wu, et al.
Molecular Cancer Therapeutics|October 10, 2019
ADP-Ribosylation Levels and Patterns Correlate with Gene Expression and Clinical Outcomes in Ovarian CancersLesley B Conrad, Ken Y Lin, Tulip Nandu, et al.
Molecular Cancer Therapeutics|March 5, 2022
Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid TumorsYukitomo Ishi, Yongzhan Zhang, Ali Zhang, et al.
Molecular Cancer Therapeutics|September 23, 2021
Growth Inhibition and Induction of Innate Immune Signaling of Chondrosarcomas with Epigenetic InhibitorsTahir N Sheikh, Xiao Chen, Xinjing Xu, et al.
Molecular Cancer Therapeutics|September 23, 2021
Monitoring Circulating Tumor DNA During Surgical Treatment in Patients with Gastrointestinal Stromal TumorsGustav Johansson, Marta Berndsen, Stefan Lindskog, et al.
Molecular Cancer Therapeutics|September 23, 2021
Targeting the IGF-Axis Potentiates Immunotherapy for Pancreatic Ductal Adenocarcinoma Liver Metastases by Altering the Immunosuppressive MicroenvironmentMasakazu Hashimoto, John David Konda, Stephanie Perrino, et al.
Molecular Cancer Therapeutics|September 16, 2018
PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to TemozolomideFumi Higuchi, Alexandria L Fink, Juri Kiyokawa, et al.
Molecular Cancer Therapeutics|December 10, 2009
Basal c-Jun NH2-terminal protein kinase activity is essential for survival and proliferation of T-cell acute lymphoblastic leukemia cellsJian Cui, Qingyang Wang, Jing Wang, et al.
Molecular Cancer Therapeutics|December 10, 2009
Angiotensin type 2 receptor-mediated apoptosis of human prostate cancer cellsHongwei Li, Yanfei Qi, Chengyao Li, et al.
Molecular Cancer Therapeutics|December 10, 2009
Antimitotic effect of the retinoid 4-oxo-fenretinide through inhibition of tubulin polymerization: a novel mechanism of retinoid growth-inhibitory activityValentina Appierto, Paola Tiberio, Elena Cavadini, et al.
Pageof 599